Pasithea Therapeutics Corp.
KTTA | NASDAQ
$0.51
-$0.01 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.49
-$0.02 (-3.73%)
Pre-market:
Sep 22, 2026, 4:27 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.06K | 15.06K | 15.06K | 15.06K | n/a | n/a | n/a |
Cost of Revenue | 473.04K | 315.5K | 157.96K | 162.26K | 162.26K | 162.26K | 162.26K | 162.22K | 162.22K | 162.22K | 162.22K | 4.14K | 4.14K | 5.1K | 18.03K | 31.17K | 31.17K | 30.21K | 17.28K | n/a | n/a | n/a |
Gross Profit | -473.04K | -315.5K | -157.96K | -162.26K | -162.26K | -162.26K | -162.26K | -162.22K | -162.22K | -162.22K | -162.22K | -4.14K | -4.14K | -5.1K | -4.37K | -2.45K | -2.45K | -1.49K | -2.21K | n/a | n/a | n/a |
Operating Income | -23.96M | -22.05M | -20.86M | -13.86M | -13.76M | -13.89M | -14.25M | -16.14M | -16.92M | -16.81M | -15.98M | -14.87M | -14.94M | -13.72M | -12.59M | -10.5M | -7.92M | -6.04M | -4.51M | -2.6M | -1.34M | -611.09K |
Interest Income | 1.09M | 730.29K | 327.19K | 225.55K | 257.23K | 317.21K | 423.18K | 515.53K | 572.19K | 574.97K | 421.76K | 249.03K | 117.29K | 102 | 102 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -21.29M | -19.73M | -20.43M | -13.49M | -13.46M | -13.61M | -13.9M | -15.76M | -16.37M | -16.1M | -15.51M | -14.53M | -15.11M | -13.7M | -11.73M | -7.04M | -4.38M | -2.92M | -2.17M | -2.85M | -1.34M | -611.09K |
Net Income | -21.29M | -19.73M | -20.43M | -13.49M | -13.46M | -13.61M | -13.9M | -15.78M | -16.39M | -16.28M | -15.96M | -16.03M | -17M | -15.9M | -12.32M | -6.57M | -3.51M | -1.58M | -2.17M | -2.85M | -1.34M | -611.09K |
Selling & General & Admin | 3.97B | 1.95B | 12.88M | 6.95M | 6.62M | 6.55M | 6.89M | 6.94M | 7.68M | 7.89M | 7.72M | 8.73M | 9.15M | 9.96M | 9.92M | 9.22M | 7.92M | 6.03M | 4.51M | 2.55M | 1.28M | 549.61K |
Research & Development | 6.63B | 2.95B | 7.98M | 6.75M | 6.97M | 7.18M | 7.2M | 9.04M | 9.08M | 8.75M | 8.1M | 6.14M | 5.79M | 3.76M | 2.67M | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -10.58B | -4.87B | -157.31K | 655 | 655 | 655 | n/a | n/a | n/a | 0 | 0 | 0 | 0 | n/a | -12.94K | 1.94M | 3.21M | 3.94M | 4.51M | 2.6M | 1.34M | 611.09K |
Operating Expenses | 23.48M | 21.74M | 20.7M | 13.7M | 13.59M | 13.73M | 14.09M | 15.98M | 16.76M | 16.65M | 15.82M | 14.87M | 14.94M | 13.72M | 12.57M | 10.49M | 7.9M | 6.02M | 4.51M | 2.6M | 1.34M | 611.09K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.39K | 6.49K | 6.49K | 6.49K | 102 | n/a | 508 | 508 | 508 | 508 | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.96M | 22.05M | 20.86M | 13.86M | 13.76M | 13.89M | 14.25M | 16.14M | 16.92M | 16.81M | 15.98M | 14.87M | 14.94M | 13.72M | 12.59M | 10.52M | 7.94M | 6.05M | 4.52M | 2.6M | 1.34M | 611.09K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 32.1M | 7.03M | 7.03M | 7.44M | 5.64M | 1.1M | 1.1M | 1.04M | 1.04M | 1.04M | 1.04M | 1.26M | 1.31M | 1.3M | 1.3M | 1.33M | 1.17M | 1.15M | 1.15M | 660.42K | 688.92K | 688.92K |
Shares Outstanding (Diluted) | 32.1M | 7.03M | 7.03M | 7.44M | 5.64M | 1.1M | 1.1M | 1.04M | 1.04M | 1.04M | 1.04M | 1.26M | 1.31M | 1.3M | 1.3M | 1.33M | 1.17M | 1.15M | 1.15M | 660.42K | 688.92K | 688.92K |
EPS (Basic) | -1.87 | -2.37 | -5.21 | -7.22 | -9.68 | -12.73 | -13.18 | -15.13 | -15.13 | -14.30 | -221.65 | -219.80 | -220.38 | -219.77 | -10.09 | -6.54 | -5.40 | -4.19 | -3.62 | -4.30 | -2.01 | -0.95 |
EPS (Diluted) | -1.87 | -2.37 | -5.21 | -7.22 | -9.68 | -12.73 | -13.18 | -15.13 | -15.13 | -14.30 | -221.65 | -219.80 | -220.38 | -219.77 | -10.09 | -6.54 | -5.40 | -4.19 | -3.62 | -4.30 | -2.01 | -0.95 |
EBITDA | -23.3M | -21.4M | -20.19M | -13.11M | -13.02M | -13.16M | -13.52M | -15.37M | -16.16M | -16.04M | -15.21M | -14.39M | -14.94M | -13.46M | -11.71M | -9.61M | -6.71M | -5.25M | -4.51M | -2.55M | -1.28M | -549.61K |
EBIT | -23.96M | -22.05M | -20.86M | -13.78M | -13.67M | -13.81M | -14.17M | -16.02M | -16.81M | -16.69M | -15.86M | -14.88M | -15.29M | -13.65M | -11.73M | -9.63M | -6.71M | -5.25M | -4.51M | -2.6M | -1.34M | -611.09K |
Depreciation & Amortization | 654.22K | 658.42K | 662.59K | 667.3K | 647.97K | 648.48K | 649.03K | 648.99K | 648.99K | 648.99K | 648.45K | 490.37K | 344.79K | 183.49K | 26.78K | 22.99K | 1.28M | 2.01M | 2.55M | 2.6M | 1.34M | 611.09K |
Add to Watchlist
Select watchlists to add or remove KTTA